Free Trial

Sotera Health (SHC) Competitors

Sotera Health logo
$11.38 -0.23 (-1.98%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$11.38 0.00 (0.00%)
As of 07:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SHC vs. HIMS, GH, OPCH, RDNT, BTSG, SGRY, PRVA, CON, WGS, and VCYT

Should you be buying Sotera Health stock or one of its competitors? The main competitors of Sotera Health include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

Sotera Health vs. Its Competitors

Sotera Health (NASDAQ:SHC) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings.

Hims & Hers Health has a net margin of 9.24% compared to Sotera Health's net margin of 2.24%. Sotera Health's return on equity of 41.08% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health2.24% 41.08% 5.68%
Hims & Hers Health 9.24%22.75%15.51%

Hims & Hers Health has higher revenue and earnings than Sotera Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.10B2.94$44.34M$0.08142.25
Hims & Hers Health$1.48B7.65$126.04M$0.6973.10

Sotera Health has a beta of 1.81, indicating that its share price is 81% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.02, indicating that its share price is 102% more volatile than the S&P 500.

Sotera Health currently has a consensus target price of $16.00, suggesting a potential upside of 40.60%. Hims & Hers Health has a consensus target price of $39.58, suggesting a potential downside of 21.53%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts plainly believe Sotera Health is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Hims & Hers Health
3 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.92

In the previous week, Hims & Hers Health had 73 more articles in the media than Sotera Health. MarketBeat recorded 74 mentions for Hims & Hers Health and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.77 beat Hims & Hers Health's score of 0.28 indicating that Sotera Health is being referred to more favorably in the media.

Company Overall Sentiment
Sotera Health Very Positive
Hims & Hers Health Neutral

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 55.1% of Sotera Health shares are owned by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Sotera Health and Hims & Hers Health tied by winning 8 of the 16 factors compared between the two stocks.

Get Sotera Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHC vs. The Competition

MetricSotera HealthMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$3.30B$7.25B$5.61B$9.29B
Dividend YieldN/A2.86%4.23%4.03%
P/E Ratio142.2734.4428.5419.58
Price / Sales2.9434.49429.2495.01
Price / Cash9.6725.1136.0257.93
Price / Book7.968.098.145.54
Net Income$44.34M$236.06M$3.24B$257.73M
7 Day Performance-1.98%-3.35%0.18%-0.08%
1 Month Performance0.53%-0.38%5.96%8.09%
1 Year Performance-11.78%19.35%26.24%13.02%

Sotera Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHC
Sotera Health
3.1961 of 5 stars
$11.38
-2.0%
$16.00
+40.6%
-6.9%$3.30B$1.10B142.273,000
HIMS
Hims & Hers Health
2.2293 of 5 stars
$48.34
+0.8%
$39.58
-18.1%
+120.8%$10.74B$1.48B70.061,637Trending News
Insider Trade
GH
Guardant Health
4.4791 of 5 stars
$49.54
-1.9%
$53.76
+8.5%
+52.5%$6.26B$739.02M-14.612,021Positive News
Analyst Upgrade
OPCH
Option Care Health
4.4948 of 5 stars
$30.91
-0.8%
$35.50
+14.8%
+2.1%$5.10B$5.00B24.938,088Positive News
RDNT
RadNet
4.0771 of 5 stars
$55.26
-1.7%
$69.60
+26.0%
-11.5%$4.22B$1.83B-128.5111,021
BTSG
BrightSpring Health Services
1.7487 of 5 stars
$22.00
-0.5%
$24.90
+13.2%
+77.2%$3.89B$11.27B78.5735,000
SGRY
Surgery Partners
2.5 of 5 stars
$22.03
-0.5%
$33.56
+52.3%
-15.2%$2.84B$3.11B-14.4015,000
PRVA
Privia Health Group
3.927 of 5 stars
$21.35
-3.4%
$27.77
+30.1%
+14.9%$2.70B$1.74B177.931,140
CON
Concentra Group Holdings Parent
2.8281 of 5 stars
$20.33
-1.1%
$28.50
+40.2%
N/A$2.64B$1.90B15.1711,250
WGS
GeneDx
3.7772 of 5 stars
$85.74
-6.4%
$90.13
+5.1%
+136.8%$2.61B$330.14M-60.811,200Analyst Downgrade
VCYT
Veracyte
3.562 of 5 stars
$26.34
-4.3%
$40.90
+55.3%
+11.7%$2.15B$445.76M64.25790News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:SHC) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners